CNSX:IMCC IM Cannabis (IMCC) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free IMCC Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get IM Cannabis alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About IM Cannabis Stock (CNSX:IMCC)IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.Read More Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. IMCC Stock News HeadlinesApril 16, 2024 | finanznachrichten.deIM Cannabis Corp.: IMC to transfer its Oranim Pharmacy shares back to the sellerApril 16, 2024 | finance.yahoo.comIMC to transfer its Oranim Pharmacy shares back to the sellerApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 4, 2024 | yahoo.comMarijuana decriminalization bill runs into opposition, remains aliveMarch 28, 2024 | markets.businessinsider.comIMCC Stock Earnings: IM Cannabis Misses EPS, Misses Revenue for Q4 2023February 12, 2024 | msn.comNew York medical cannabis bills in legislature aim for reciprocity, nixing excise taxesJanuary 31, 2024 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price RuleJanuary 31, 2024 | finance.yahoo.comIM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price RuleApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.December 8, 2023 | msn.comWar In Gaza Forces Israel To Delay Medical Cannabis ReformNovember 13, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Reports Third Quarter 2023 Financial ResultsNovember 13, 2023 | finance.yahoo.comIM Cannabis Reports Third Quarter 2023 Financial ResultsSeptember 19, 2023 | finance.yahoo.comIM Cannabis Announces CFO DepartureAugust 28, 2023 | finance.yahoo.comIs IM Cannabis (IMCC) Too Good to Be True? A Comprehensive Analysis of a Potential Value TrapAugust 11, 2023 | markets.businessinsider.comThese Companies Are Ready To Capitalize On Latest Marijuana Reforms In Israel And GermanyAugust 4, 2023 | marketwatch.comIM Cannabis Notified Over Lack of Compliance with Nasdaq Listing RequirementsAugust 1, 2023 | msn.comLocal cannabis dispensary chain shut down amid crackdownJuly 13, 2023 | benzinga.com'GOP-Controlled House Committee Blocks Every Marijuana And Psychedelics Amendment To Defense Bill From Getting Floor Vote' - Marijuana MomentJune 13, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price RequirementJune 13, 2023 | msn.comIM Cannabis regains compliance with Nasdaq's minimum bid price requirementJune 13, 2023 | finance.yahoo.comIM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price RequirementMay 15, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Reports First Quarter 2023 Financial Results; Gross Profit Increased 46% Year-over-YearMay 15, 2023 | finance.yahoo.comIM Cannabis Reports First Quarter 2023 Financial Results; Gross Profit Increased 46% Year-over-YearMay 8, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Completes Debt Settlement with L5 CapitalMay 8, 2023 | finance.yahoo.comIM Cannabis Completes Debt Settlement with L5 CapitalMay 8, 2023 | finance.yahoo.comIM Cannabis to Report First Quarter 2023 Financial Results on Monday, May 15 at 9:00am ETApril 28, 2023 | finanznachrichten.deIM Cannabis Corp.: IM Cannabis Announces Units for Debt SettlementSee More Headlines Receive IMCC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IM Cannabis and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:IMCC CUSIPN/A CIKN/A Webwww.imcannabis.com Phone972 7 7444 2333FaxN/AEmployees95Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Marc Lustig M.B.A. (Age 50)M.Sc., Executive Chairman Comp: $129.92kMr. Oren ShusterCEO & DirectorMr. Uri Birenberg (Age 48)Chief Financial Officer Comp: $325.71kMr. Richard BallaChief Executive Officer of AdjupharmAdvocate Michal Lebovitz NissimovGeneral CounselKey CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBio-Rad LaboratoriesCNSX:BIOBlueberries MedicalCNSX:BBMView All Competitors IMCC Stock Analysis - Frequently Asked Questions How do I buy shares of IM Cannabis? Shares of IMCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:IMCC) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IM Cannabis Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
